Deflazacort

Is a synthetic glucocorticoid (corticosteroid).

Treatment of inflammatory and allergic conditions

Management of various autoimmune diseases

Relief of symptoms in conditions like asthma, allergic rhinitis, and eczema

Treatment of certain types of shock

Adjunctive therapy in certain cancers and neurological conditions (as directed by a physician)

Tedos 12 Tablet (Deflazacort) binds to glucocorticoid receptors in cells, influencing gene expression and leading to anti-inflammatory, immunosuppressive, and metabolic effects. It reduces inflammation by inhibiting the release of inflammatory mediators and suppressing the immune response.

Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children. Discard any unused medication after the expiry date.

Dosage is determined by the physician based on the specific condition, severity, and patient's response.

Dosage may vary widely depending on the condition being treated.

Follow your doctor's instructions exactly.

Do not abruptly stop taking deflazacort without consulting your doctor.

Increased appetite and weight gain

Fluid retention (edema)

Mood changes (irritability, depression, anxiety)

High blood sugar (hyperglycemia)

Increased risk of infections

Osteoporosis (weakening of bones)

Muscle weakness

Cataracts and glaucoma (eye problems)

Skin thinning and bruising

High blood pressure

Alcohol Consumption

Alcohol consumption may increase the risk of side effects, including stomach upset and liver problems. Consult your doctor.



While Driving or operating Machinery

Deflazacort may cause drowsiness, dizziness, or blurred vision. Avoid driving or operating machinery if affected.



Pregnant & Breastfeeding Women

Use during pregnancy and breastfeeding is generally avoided unless the benefits outweigh the potential risks. Consult your doctor.



Children

Dosage adjustments may be needed for children. A physician will determine the appropriate dose.



Kidney

Patients with kidney disease may require dosage adjustments. Close monitoring is needed.



Liver

Deflazacort is primarily metabolized by the liver. Patients with liver disease may require dosage adjustments and close monitoring.

Consult your physician or pharmacist for complete prescribing information.

Refer to the medication's package insert for detailed instructions.